Generic

Linagliptin 2.5mg + Metformin Hydrochloride 1000mg

Description

Lijenta-MX 2.5 is a combination medication used to control high blood sugar in individuals with type 2 diabetes mellitus. It enhances glycemic control through Linagliptin, a DPP-4 inhibitor, and Metformin, an antihyperglycemic agent. This combination is prescribed to lower blood sugar levels when diet and exercise alone are insufficient.

Benefits

• Helps control blood sugar in type 2 diabetes patients.
• Reduces the risk of severe diabetes complications.
• Can be combined with other diabetes medications for improved results.
• Minimizes the likelihood of weight gain and low blood sugar compared to other treatments.

Ingredients

Linagliptin 2.5mg, Metformin Hydrochloride 1000mg

Uses and Doses

Lijenta-MX 2.5 is prescribed for adults with type 2 diabetes mellitus, along with diet and exercise. The extended-release tablet is taken once daily with a meal, not exceeding 5mg of Linagliptin and 2000mg of Metformin Hydrochloride. Dosage should be adjusted based on efficacy and tolerance.

Side Effects

Common side effects include diarrhea, nausea, vomiting, upset stomach, headache, nasal congestion, sore throat, and respiratory infections. Hypoglycemia may occur when combined with insulin or sulfonylureas.

How to Use

Take Lijenta-MX 2.5 as directed by your physician. Swallow the tablet whole with food to reduce gastrointestinal discomfort. Do not crush, chew, or break the tablet.

Pregnancy & Lactation

Lijenta-MX 2.5 should only be used during pregnancy if necessary, as there is limited research on its safety. Caution is advised for nursing mothers due to the potential risk of hypoglycemia in infants.

Precautions and Warnings

• Discontinue immediately if lactic acidosis is suspected.
• Monitor kidney function regularly.
• Avoid use in patients with renal impairment or metabolic acidosis.
• Temporarily stop before undergoing radiologic procedures with iodinated contrast or surgery.

Safety Information

Monitor blood sugar regularly while on this medication. Report any severe gastrointestinal symptoms, as they may indicate lactic acidosis. Avoid alcohol as it increases the risk of hypoglycemia.

Indications

Type 2 diabetes mellitus, for patients requiring combination therapy with Linagliptin and Metformin Hydrochloride.

Pharmacology

Linagliptin inhibits DPP-4, increasing incretin hormones that regulate insulin and glucagon levels. Metformin reduces glucose production and increases insulin sensitivity.

Therapeutic Class

Combination Oral Hypoglycemic Agents

Storage Conditions

Store in a cool, dry place away from light and heat. Keep out of children's reach.

3 FAQ

Q1: Can Lijenta-MX 2.5 cause weight gain?
A1: Lijenta-MX 2.5 is less likely to cause weight gain compared to other diabetes medications.

Q2: How often should I take Lijenta-MX 2.5?
A2: Follow your doctor's recommendation, but typically it is taken once daily with a meal.

Q3: Is Lijenta-MX 2.5 safe during pregnancy?
A3: It should only be taken during pregnancy if necessary; consult your doctor.

Disclaimer

Always consult your healthcare provider to ensure the information applies to your circumstances.

Keywords: Linagliptin, metformin hydrochloride, type 2 diabetes, glycemic control, DPP-4 inhibitor, antihyperglycemic, diabetes treatment, diabetes medication, extended-release, blood sugar control, diabetes management, oral hypoglycemic, diabetic complications, lactic acidosis, insulin sensitivity, diabetic therapy, metformin side effects, sugar levels, diabetes prevention, diabetes care.